Skip to main content
. Author manuscript; available in PMC: 2014 Dec 29.
Published in final edited form as: Ann Emerg Med. 2013 Apr 6;62(4):311–318.e4. doi: 10.1016/j.annemergmed.2013.03.017

Table 1.

Baseline characteristics of entire study population

Characteristic Ketorolac (n=60) Metoclopramide +
diphenhydramine (n=60)
Median age in years (IQR) 38 (26, 46) 38 (29, 48)
Female, n (%) 48 (80%) 42 (70%)
Race/ ethnicity, n (%)
Asian 0 0
Black 11 (18%) 17 (28%)
Latino 40 (67%) 34 (57%)
White 1 (2%) 2 (3%)
Mixed 3 (5%) 4 (7%)
Other 5 (8%) 2 (3%)
Refused 0 1 (2%)
Median duration of headache in hours (IQR) 72 (48, 168) 72 (24, 144)
Median number of days with headache over the previous 3 months (IQR) 5 (2, 10) 5 (2,10)
Past medical history of migraine headaches n (%) 16 (27%) 11 (18%)
Median baseline NRS pain score, on a scale from 0–10 with 0= no pain and 10= worst imaginable (IQR) 8 (7, 10) 8 (7, 9)